Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve NHS diagnostic processes for glioblastoma brain tumours.

The Department is working with NHS England in taking steps to improve diagnostic processes in the National Health Service for all patients with cancer, including those with glioblastoma brain tumours.

We will get the NHS diagnosing cancer, including brain tumours, on time, diagnosing it earlier and treating it faster so more patients survive, and we will improve patients’ experience across the system. We will address the challenges in diagnostic waiting times, providing the number of CT, magnetic resonance imaging and other tests that are needed to reduce cancer waits.

To do this, we set out expectations for renewed focus on cancer targets in the Elective Reform plan, published on 6 January 2025. We have asked systems and providers to identify local opportunities in both community diagnostic centres (CDCs) and hospital based diagnostic services to improve performance against the Faster Diagnosis Standard, to reduce the number of patients waiting too long for a confirmed diagnosis of cancer. Any new CDCs will be expected to include specific capacity for cancer testing as part of activity plans, enabled either through direct provision or via freeing up acute hospital capacity for more complex cancer tests.

In September 2024, the National Institute for Health and Care Research (NIHR) announced new research funding opportunities for brain cancer research, including glioblastoma, spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure the most promising research opportunities are made available to adult and child patients and a new funding call to generate high quality evidence in brain tumour care, support, and rehabilitation.